MiR-30a in B-cell lymphoma targeted suppressor of cytokine signaling 3 (SOCS3), activating JAK-STAT3 signaling and promoting MDSC differentiation and immunosuppression [115]. Here, SOCS3 is linked to B-cell non-Hodgkin lymphoma.